Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
14.67
-0.07 (-0.47%)
At close: Apr 28, 2026, 4:00 PM EDT
14.67
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:06 PM EDT
Omeros Employees
Omeros had 175 employees as of December 31, 2025. The number of employees decreased by 27 or -13.37% compared to the previous year.
Employees
175
Change (1Y)
-27
Growth (1Y)
-13.37%
Revenue / Employee
n/a
Profits / Employee
-$19,143
Market Cap
1.06B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,300 |
| Xeris Biopharma Holdings | 435 |
| KalVista Pharmaceuticals | 275 |
| uniQure | 221 |
| EyePoint | 214 |
| Zenas BioPharma | 167 |
| Septerna | 130 |
| ORIC Pharmaceuticals | 104 |
OMER News
- 12 days ago - CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug) - Business Wire
- 4 weeks ago - Omeros Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results - Business Wire
- 4 weeks ago - Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026 - Business Wire
- 5 weeks ago - Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment - Business Wire
- 2 months ago - Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program - Business Wire
- 3 months ago - Omeros Announces First Commercial Sales of YARTEMLEA® - Business Wire
- 3 months ago - Omeros prices transplant complication drug at $36,000 per dose - Reuters